Delivery Order SPE2DB24D1021-SPE2DB25FEXWE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $2,675.40. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyvanse 30 mg capsules (100 count) with a ceiling value of $2,708.64. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on June 3, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Vyvanse 50 mg capsules (100 count) with a ceiling value of $2,193.53. This firm fixed-price delivery order is set to be completed by July 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement conducted through the federal contracting system. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $5,486.46. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The order is set for ultimate completion on August 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyvanse 10 mg capsules (100-count units) with a contract ceiling value of $1,333.84. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Vyvanse 30 mg capsules (100 count) valued at $3,567.20. This is a firm fixed-price contract with no set-aside designation, utilizing competitive procurement procedures. The delivery order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyvanse 60 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $3,122.35. The delivery order represents a non-set-aside, competitively awarded procurement with an ultimate completion date of June 3, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 70 mg capsules (100-count units) with a contract ceiling value of $1,440.16. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a contract ceiling value of $3,545.56. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is set for ultimate completion on May 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXWEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $2,111.38. This competitively awarded, firm fixed-price delivery order is set to be completed by June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 and extending through December 2026. That prime contract enables the company to supply a broad range of pharmaceuticals, medical devices, and healthcare commodities to support military healthcare programs globally. As one of the federal government's critical pharmaceutical distributors, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle, which positions the company as a key supplier within the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/18/25 |